David M. Reid

Q: What Schools Are Affiliated With David M. Reid

David M. Reid is affiliated with the following schools: University of Aberdeen, University of Surrey

David M. Reid's AcademicInfluence.com Rankings

David M. Reid

Biology

#11271

World Rank

#14656

Historical Rank

Genetics

#1216

World Rank

#1317

Historical Rank

Neuroscience

#1815

World Rank

#1871

Historical Rank

Biochemistry

#1849

World Rank

#1989

Historical Rank

biology Degrees

Download Badge

Biology

David M. Reid's Degrees

PhD Genetics Stanford University
Masters Biology University of California, San Francisco
Bachelors Biochemistry University of California, Berkeley

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is David M. Reid Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David M. Reid's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci (2010) (1285)
Common genetic determinants of vitamin D insufficiency: a genome-wide association study (2010) (1177)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture (2012) (1045)
Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS) (2002) (645)
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene (1996) (641)
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls (2010) (600)
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. (2003) (544)
Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial (2000) (531)
Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? (2000) (511)
Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy (2000) (482)
Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls (2010) (465)
Rheumatoid arthritis association at 6q23 (2007) (423)
Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. (1997) (412)
A Meta‐Analysis of the Association of Fracture Risk and Body Mass Index in Women (2014) (397)
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. (2009) (386)
HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTION (1985) (381)
Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. (2004) (360)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial (2009) (349)
Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk (2009) (343)
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update (1998) (337)
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. (2004) (324)
Incidence of Distal Forearm Fracture in British Men and Women (2001) (289)
Association of Five Quantitative Ultrasound Devices and Bone Densitometry With Osteoporotic Vertebral Fractures in a Population‐Based Sample: The OPUS Study (2004) (266)
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. (2008) (262)
Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk (2011) (262)
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. (2006) (258)
The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis (2006) (254)
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. (2013) (250)
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS) (2003) (236)
Incidence of Limb Fracture across Europe: Results from the European Prospective Osteoporosis Study (EPOS) (2002) (233)
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. (2000) (229)
Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. (2008) (229)
Mortality Associated with Vertebral Deformity in Men and Women: Results from the European Prospective Osteoporosis Study (EPOS) (1998) (229)
Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. (2012) (201)
Low dietary potassium intakes and high dietary estimates of net endogenous acid production are associated with low bone mineral density in premenopausal women and increased markers of bone resorption in postmenopausal women. (2005) (194)
Management of male osteoporosis: report of the UK Consensus Group. (1998) (194)
The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey. (1999) (194)
Bone Density Variation and Its Effects on Risk of Vertebral Deformity in Men and Women Studied in Thirteen European Centers: The EVOS Study (1997) (194)
Health-related quality of life and radiographic vertebral fracture (2004) (186)
Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study (2006) (185)
Prevalent Vertebral Deformity Predicts Incident Hip though not distal Forearm Fracture: Results from the European Prospective Osteoporosis Study (2001) (182)
Factors associated with onset of menopause in women aged 45-49. (1994) (181)
Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. (1996) (178)
Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? (2011) (178)
Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. (1992) (175)
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. (2016) (172)
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13 (2008) (170)
Estrogen Receptor α Gene Polymorphisms and Bone Mineral Density: Haplotype Analysis in Women from the United Kingdom (2001) (168)
Mothers and daughters menopausal ages: is there a link? (1997) (168)
Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial. (2008) (163)
Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility (2008) (163)
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. (2008) (162)
Lasofoxifene in postmenopausal women with osteoporosis. (2010) (156)
Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy (2001) (153)
Growth of C57Bl/6 Mice and the Material and Mechanical Properties of Cortical Bone from the Tibia (2004) (152)
The Effects of Lifestyle, Dietary Dairy Intake and Diabetes on Bone Density and Vertebral Deformity Prevalence: The EVOS Study (2001) (149)
Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. (2008) (148)
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. (2001) (147)
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. (2005) (145)
Lower estimates of net endogenous non-carbonic acid production are positively associated with indexes of bone health in premenopausal and perimenopausal women. (2004) (142)
Influence of LRP5 Polymorphisms on Normal Variation in BMD (2004) (138)
Prediction of perimenopausal fractures by bone mineral density and other risk factors (1996) (138)
Evidence for a Pathogenic Role of Nitric Oxide in Inflammation‐Induced Osteoporosis (1999) (137)
Age and sex influences on fall characteristics. (1994) (136)
Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate:creatinine ratio. (1996) (136)
Radiographic features of lumbar disc degeneration and self-reported back pain. (2004) (136)
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. (2010) (133)
Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole (2008) (126)
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. (2013) (122)
Back pain, disability, and radiographic vertebral fracture in European women: a prospective study (2004) (119)
PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population (2009) (118)
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. (2010) (114)
Defective Bone Formation and Anabolic Response to Exogenous Estrogen in Mice with Targeted Disruption of Endothelial Nitric Oxide Synthase**This study was supported by grants from the Arthritis Research Campaign (UK) and the Medical Research Council (UK). (2001) (114)
Population-based geographic variations in dxa bone density in Europe: The evos study (1997) (113)
Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy (2003) (112)
Dietary patterns, bone resorption and bone mineral density in early post-menopausal Scottish women (2011) (111)
Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. (2009) (111)
Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. (2001) (109)
Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease (2010) (107)
Steroid induced osteoporosis: an opportunity for prevention? (1995) (106)
Osteoporosis and its management. (1999) (106)
Associations between dietary flavonoid intakes and bone health in a scottish population (2011) (105)
A method for assessment of the shape of the proximal femur and its relationship to osteoporotic hip fracture (2004) (105)
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23 (2009) (102)
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. (2005) (101)
Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study. (2004) (101)
Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes (2009) (96)
Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. (1995) (95)
Bone density and bone turnover in patients with osteoarthritis and osteoporosis. (1999) (94)
Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: Results from the 1958 British Birth Cohort Study (2010) (94)
Alcohol consumption and age of maternal menopause are associated with menopause onset. (1997) (94)
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. (2008) (92)
Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. (1997) (90)
Large‐Scale Population‐Based Study Shows No Evidence of Association Between Common Polymorphism of the VDR Gene and BMD in British Women (2005) (90)
Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. (2011) (89)
Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. (2010) (89)
Randomized controlled trial of hip protectors among women living in the community (2004) (86)
Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. (2012) (85)
Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. (2008) (85)
Dietary silicon interacts with oestrogen to influence bone health: evidence from the Aberdeen Prospective Osteoporosis Screening Study. (2012) (84)
Decreased axial and peripheral bone density in patients taking long-term warfarin. (1995) (81)
Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study (2009) (81)
Prediction of fractures in perimenopausal women: a comparison of dual energy x ray absorptiometry and broadband ultrasound attenuation. (1996) (80)
Lumbar disc degeneration: association between osteophytes, end-plate sclerosis and disc space narrowing (2006) (80)
Association of oestrogen receptor α gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone (2005) (79)
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort. (1991) (78)
The characterisation and determinants of quality of life in ANCA associated vasculitis (2013) (78)
Bone-density measurement (1992) (76)
COL1A1 Sp1 Polymorphism Predicts Perimenopausal and Early Postmenopausal Spinal Bone Loss (2001) (76)
Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. (2004) (76)
Radiographic features of lumbar disc degeneration and bone mineral density in men and women (2005) (75)
Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women (2012) (75)
Patterns of dietary intake and serum carotenoid and tocopherol status are associated with biomarkers of chronic low-grade systemic inflammation and cardiovascular risk (2014) (74)
Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). (2007) (73)
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT) (2016) (73)
Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS) (2010) (72)
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? (2001) (71)
Association Between COLIA1 Sp1 Alleles and Femoral Neck Geometry (2001) (66)
Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: A 1‐year double‐blind RCT in postmenopausal women (2013) (65)
European semi-anthropomorphic spine phantom for the calibration of bone densitometers: Assessment of precision, stability and accuracy the European quantitation of osteoporosis study group (1995) (65)
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids (2004) (61)
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (61)
Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids. (1993) (61)
Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population (2009) (61)
Dual X‐ray absorptiometry of the proximal femur: Normal european values standardized with the european spine phantom (1995) (61)
Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women. (2006) (61)
Bone mineral density (BMD) in patients with lymphoma: The effects of chemotherapy, intermittent corticosteroids and premature menopause (1992) (59)
Prediction of Osteoporotic Fractures by Bone Densitometry and COLIA1 Genotyping: A Prospective, Population-Based Study in Men and Women (2001) (59)
Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. (2010) (59)
Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometry. (2002) (59)
Susceptibility to Osteoporotic Fracture is Determined by Allelic Variation at the Sp1 Site, Rather than Other Polymorphic Sites at the COL1A1 Locus (2000) (59)
Private versus social opportunity cost of time: valuing time in the demand for health care. (1994) (59)
Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results. (1997) (58)
Predicting OA progression to total hip replacement: can we do better than risk factors alone using active shape modelling as an imaging biomarker? (2012) (58)
Influence of weight, body mass index and lifestyle factors on radiographic features of lumbar disc degeneration (2007) (56)
Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study. (1992) (56)
Screening for osteoporosis: Comparison between dual energy X-ray absorptiometry and broadband ultrasound attenuation in 1000 perimenopausal women (1993) (55)
FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK (2015) (54)
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. (2010) (54)
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. (2008) (52)
Identification of hip fracture patients from radiographs using Fourier analysis of the trabecular structure: a cross-sectional study (2004) (51)
Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women (2005) (50)
FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study (2013) (50)
A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24‐month results from FACTS‐International (2008) (50)
Falls explain between-center differences in the incidence of limb fracture across Europe. (2002) (50)
Relationship of urinary pyridinium crosslinks to disease extent and activity in osteoarthritis. (1994) (50)
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk (2010) (49)
Can we improve the prediction of hip fracture by assessing bone structure using shape and appearance modelling? (2013) (49)
Explaining fatigue in ANCA-associated vasculitis. (2013) (49)
Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts (2014) (48)
Predicting a second hip fracture. (1999) (48)
Hormone replacement therapy: compliance and cost after screening for osteoporosis. (1995) (47)
Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms. (2002) (47)
Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. (2002) (46)
Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis: Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial (2010) (46)
Longitudinal changes in dietary intake in Scottish women around the menopause: changes in dietary pattern result in minor changes in nutrient intake (2005) (45)
Can radiologists detect osteopenia on plain radiographs? (1994) (44)
Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57°N and 51°N: A longitudinal study (2010) (44)
Seasonal differences in biochemical parameters of bone remodelling. (1996) (43)
Bone Density in Asthmatic Patients Taking Inhaled Corticosteroids: Comparison of Budesonide and Beclomethasone Dipropionate (1996) (43)
Role of bisphosphonates in the management of postmenopausal osteoporosis: an update on recent safety anxieties (2011) (42)
Bone Shape, Structure, and Density as Determinants of Osteoporotic Hip Fracture: A Pilot Study Investigating the Combination of Risk Factors (2005) (42)
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study (2006) (42)
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. (2008) (42)
Life-style, environmental and medical factors influencing peak bone mass in women. (1995) (42)
Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. (2014) (39)
Geographic and other determinants of BMD change in European men and women at the hip and spine. a population-based study from the Network in Europe for Male Osteoporosis (NEMO). (2007) (39)
The functional ACTN3 577X variant increases the risk of falling in older females: results from two large independent cohort studies. (2011) (39)
UK clinical guideline for the prevention and treatment of osteoporosis (2022) (39)
Polymorphisms of the CLCN7 Gene Are Associated With BMD in Women (2005) (38)
Quantitative ultrasound or clinical risk factors--which best identifies women at risk of osteoporosis? (2000) (38)
RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index. (2004) (37)
Screening Elderly Women for Risk of Future Fractures—Participation Rates and Impact on Incidence of Falls and Fractures (2005) (37)
Brief Report: Predicting Functional Disability: One‐Year Results From the Scottish Early Rheumatoid Arthritis Inception Cohort (2016) (36)
Association Between a Polymorphism Affecting an AP1 Binding Site in the Promoter of the TCIRG1 Gene and Bone Mass in Women (2003) (35)
Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis (2006) (35)
Skin color change in Caucasian postmenopausal women predicts summer-winter change in 25-hydroxyvitamin D: findings from the ANSAViD cohort study. (2011) (35)
No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort (2009) (34)
A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus (2013) (34)
Using Economics to Prioritize Research: A Case Study of Randomized Trials for the Prevention of Hip Fractures Due to Osteoporosis (1996) (33)
Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy (2016) (33)
A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity? (2013) (32)
Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study. (1993) (32)
Vertebral fractures in men and women: how discriminative are bone mass measurements? (1995) (32)
Common genetic determinants of vitamin D insufficiency (2011) (32)
Quantitative ultrasound in osteoporosis. (2002) (32)
Nutritional influences on bone mass (1997) (31)
Cross-calibration of dual-energy X-ray densitometers for a large, multi-center genetic study of osteoporosis (2005) (31)
Drug Insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective (2008) (31)
Bone turnover markers after the menopause: T-score approach. (2018) (31)
Precision of quantitative ultrasound: comparison of three commercial scanners. (2000) (31)
Effects of Menstrual History and Use of Medications on Bone Mineral Density: The EVOS Study (1998) (30)
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis (2012) (30)
Appendicular measurements in screening women for low axial bone mineral density. (1996) (30)
Is there a role for vitamin D in the treatment of chronic pain? (2017) (29)
The pattern of rheumatoid arthritis in West Africa and comparison with a cohort of British patients. (1991) (27)
Changes in vitamin biomarkers during a 2-year intervention trial involving increased fruit and vegetable consumption by free-living volunteers (2009) (27)
Association between TNFRSF1B polymorphisms and bone mineral density, bone loss and fracture (2004) (27)
Reproducibility and Diagnostic Accuracy of Kellgren-Lawrence Grading for Osteoarthritis Using Radiographs and Dual-Energy X-ray Absorptiometry Images. (2015) (27)
Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state. (2014) (26)
Use of digital x ray radiogrammetry in the assessment of joint damage in rheumatoid arthritis (2005) (25)
A Rare Haplotype in the Upstream Regulatory Region of COL1A1 Is Associated With Reduced Bone Quality and Hip Fracture (2009) (25)
Falling and perimenopausal women. (1993) (25)
PTHR1 Polymorphisms Influence BMD Variation through Effects on the Growing Skeleton (2007) (24)
Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. (2009) (24)
Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. (2014) (24)
Interspecies synteny mapping identifies a quantitative trait locus for bone mineral density on human chromosome Xp22. (2005) (23)
The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank (2016) (23)
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science (2008) (23)
Prevention of osteoporosis after breast cancer. (2009) (23)
Axial BMD, change in BMD and bone turnover do not predict breast cancer incidence in early postmenopausal women (2005) (23)
Relationship between risk factors and QUS in a European Population: The OPUS study. (2006) (22)
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group (2020) (21)
International variation in proximal femur bone mineral density (2009) (21)
Large‐Scale Population‐Based Study Shows No Association Between Common Polymorphisms of the TGFB1 Gene and BMD in Women (2006) (21)
No evidence that the skeletal non-response to potassium alkali supplements in healthy postmenopausal women depends on blood pressure or sodium chloride intake (2012) (21)
Cost-Effectiveness of Hormone Replacement Therapy for Fracture Prevention in Young Postmenopausal Women: An Economic Analysis Based on a Prospective Cohort Study (2002) (20)
A European multicenter comparison of quantitative ultrasound measurement variables: The OPUS study (2012) (20)
Can peripheral DXA measurements be used to predict fractures in elderly women living in the community? (2005) (20)
Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci (2009) (19)
Methods of measurement of bone turnover and clinical evaluation of osteoporosis: relevance to asthma and corticosteroid therapy. (1993) (19)
Meta-analysis of cigarette smoking, bone mineral density, and risk of hip fracture (1998) (19)
Fall frequency and incidence of distal forearm fracture in the UK. (1995) (19)
Estimating the point accuracy of population registers using capture-recapture methods in Scotland. (1996) (19)
Characterization of Common Genetic Variants in Cathepsin K and Testing for Association With Bone Mineral Density in a Large Cohort of Perimenopausal Women From Scotland (2003) (19)
Physical activity and dietary calcium interactions in bone mass in Scottish postmenopausal women (2009) (18)
Correcting calf girth discriminates the incidence of falling but not bone mass by broadband ultrasound attenuation in elderly female subjects. (2002) (18)
The economics of osteoporosis and its prevention. A review. (1997) (18)
Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UK (2006) (18)
Direct Disclosure of Bone Density Results to Patients: Effect on Knowledge of Osteoporosis Risk and Anxiety Level (1998) (18)
Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over (2015) (17)
Seasonal Variation in 25(OH)D at Aberdeen (57°N) and Bone Health Indicators– Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency? (2013) (17)
Recommendations for the Registration of Agents Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (1996) (17)
Clinical trials in rheumatoid arthritis and osteoarthritis (2008) (17)
A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis (2009) (16)
Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids. (2013) (16)
Newer drug treatments: their effects on fracture prevention. (2005) (16)
Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study (2012) (15)
Nutrition and bone: is there more to it than just calcium and vitamin D? (2001) (15)
Osteoporosis prevention through screening: will it be cost effective? (1993) (15)
Once-monthly dosing: an effective step forward. (2006) (15)
The economics of osteoporosis prevention (1997) (15)
Prevalence of hip fracture risk factors in women aged 70 years and over. (2000) (14)
Degenerative inter-vertebral disc disease osteochondrosis intervertebralis in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over (2017) (14)
Is screening for osteoporosis worthwhile? (1998) (14)
Zoledronate. (2020) (13)
Arthritis at the Menopause (1999) (13)
Breast vasculitis in association with breast gigantism in a pregnant patient with systemic lupus erythematosus. (1991) (13)
Lifestyle factors for promoting bone health in older women. (2004) (13)
Hypothalamic-pituitary-adrenal axis suppression after repeated intra-articular steroid injections. (1986) (13)
Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study (2015) (12)
Endogenous Estradiol and The Risk of Incident Fracture in Postmenopausal Women: The OPUS Study (2012) (12)
A high anticholinergic burden is associated with a history of falls in the previous year in middle-aged women: findings from the Aberdeen Prospective Osteoporosis Screening Study. (2018) (12)
Predictors of disability in early inflammatory arthritis 1 Predicting functional disability : One year results from the Scottish Early Rheumatoid Arthritis Inception Cohort (2016) (12)
Bisphosphonate-associated osteonecrosis of the jaw (2007) (12)
Is the predictive power of previous fractures for new spine and non-spine fractures associated with biochemical evidence of altered bone remodelling? The EPOS study. European Prospective Osteoporosis Study. (2002) (11)
Sunlight or diet: what is the answer for providing sufficient vitamin D in the U.K.? (2010) (11)
Fatigue-related brain white matter changes in granulomatosis with polyangiitis. (2013) (10)
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science (2008) (10)
Recruitment methods for screening programmes: the price of high compliance. (1993) (10)
Polymorphisms in the P 2 X 7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women (2014) (10)
O3. Detection of increased nitric oxide production in rheumatoid arthritis using the urinary nitrate/creatinine ratio (1996) (9)
Fruit and Vegetable Consumption and Bone Health: Is There a Link? (1998) (9)
Estimating the cost effectiveness of screening tests. (1997) (9)
Corticosteroid-induced osteoporosis: guidelines for prevention--are they useful? (1997) (9)
Tree-structured subgroup analysis of receiver operating characteristic curves for diagnostic tests. (2012) (9)
Alcohol consumption may influence onset of the menopause (1997) (9)
Essential mineral and trace element nutriture methodology (1991) (9)
Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. (2012) (8)
A comparison of radial peripheral quantitative computed tomography, calcaneal ultrasound, and axial dual energy X-ray absorptiometry measurements in women aged 45-55 yr. (1999) (8)
Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Group for the Respect of Ethics and Excellence in Science (GREES): rheumatoid arthritis section. (1998) (8)
Update on the Use of Zoledronic Acid in the Management of Osteoporosis (2010) (8)
Radial Bone Mineral Density and Estimated Rates of Change in Normal Scottish Women: Assessment by Peripheral Quantitative Computed Tomography (1999) (7)
Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women. (2009) (7)
MATERNAL GESTATIONAL VITAMIN D SUPPLEMENTATION RESULTS IN GREATER BONE MASS FOR OFFSPRING BORN DURING WINTER MONTHS: THE MAVIDOS MULTICENTRE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (2016) (7)
Corrigendum to "Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013" [Maturitas 75 (2013) 392-396] (DOI:10.1016/j.maturitas.2013.08.006) (2013) (7)
THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women. (2014) (7)
Hypothalamic-pituitary-adrenal (HPA) axis function in patients receiving long-term intra-articular corticosteroids (1983) (7)
Two year double blind randomized controlled trial in postmenopausal women shows no gain in BMD with potassium citrate treatment. (2006) (6)
Ibandronate: An IV injection for the treatment for postmenopausal osteoporosis (2007) (6)
Aberdeen Prospective Osteoporosis Screening Study is there an association between falls and vitamin D receptor gene polymorphisms (2006) (6)
EFFECTIVENESS OF MATERNAL VITAMIN D SUPPLEMENTATION: A MULTICENTRE RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL (MAVIDOS) (2015) (5)
Food groups affecting perimenopausal and early postmenopausal bone loss in Scottish women. (2001) (5)
Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture? (2007) (5)
Risedronate is effective and well tolerated in treating corticosteroid-induced osteoporosis. (1998) (5)
High body mass index, adjusted for BMD, is a risk factor for fracture in women (2012) (5)
EPIDEMIOLOGICAL INVESTIGATION INTO THE INFLUENCE OF NUTRIENT INTAKE ON BONE MINERAL DENSITY (1997) (5)
Correction: UK clinical guideline for the prevention and treatment of osteoporosis (2022) (5)
Population screening for low bone mineral density: Do non-attenders have a lower risk of osteoporosis? (1994) (4)
Handbook of Osteoporosis (2011) (4)
383 KNEE JOINT SHAPE ASSESSED BY ACTIVE SHAPE MODELLING OF PLAIN RADIOGRAPHS IS RELATED TO OSTEOARTHRITIS SEVERITY (2009) (4)
Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen prospective osteoporosis screening study (APOSS) (2020) (4)
CORTICOSTEROID-INDUCED OSTEOPOROSIS AND HORMONE IMPLANTS (1989) (4)
Managing osteoporosis (1996) (4)
The Economics of Osteoporosis and Its Prevention (1997) (4)
LOCI FOR REGULATION OF BMD IN MEN AND WOMEN THE FAMOS STUDY (2004) (3)
Vitamin D receptor alleles, bone mineral density and osteoporotic fracture: studies in a UK population (1995) (3)
Alternative population sampling frames produced important differences in estimates of association: a case-control study of vasculitis. (2013) (3)
How valid is it to conclude that long‐term heparin use is not associated with osteoporosis? (2007) (3)
Bone density varies between eleven populations participating in the European Prospective Osteoporosis Study (EPOS). (1994) (3)
The response of bone turnover markers to lasofoxifene: The PEARL trial (2009) (3)
Secondary osteoporosis. (1997) (3)
Statistical shape modelling provides a responsive measure of morphological change in knee osteoarthritis over 12 months. (2020) (3)
029 TEMPORAL STRUCTURAL CHANGES IN HIP OA DETECTED BY SHAPE AND APPEARANCE MODELLING OF DXA IMAGES: A ONE-YEAR PROSPECTIVE LONGITUDINAL STUDY (2009) (2)
Correction: Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study (2006) (2)
Non-steroidal anti-inflammatory drugs and atherothrombotic risk in older patients: where do we stand? (2010) (2)
Biomarkers of osteoarthritis progression (2013) (2)
Erratum to: Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern? (2011) (2)
Bone Mineral Density Measurements: Are they Worth While? (1996) (2)
355 VALIDATION OF SELF-REPORTED OSTEOARTHRITIS IN A POSTMENOPAUSAL POPULATION AND ITS ASSOCIATIONWITH BODY WEIGHT (2010) (2)
95043686 Steroid induced osteoporosis: An opportunity for prevention? (1995) (2)
Investigation and diagnosis (2011) (2)
Reevaluation of the Interaction Between HLA-DRB1 Shared Epitope Alleles, PTPN22, and Smoking in Determining Susceptibility to Autoantibody-Positive and Autoantibody-Negative Rheumatoid Arthritis in a Large UK Caucasian Population (vol 60, pg 2565, 2009): Erratum (2011) (2)
Fibromyalgia (FM) is not a clinical characteristic of ANCA-Associated Vasculitis (AAV) in Northern Scotland (2009) (2)
Osteoporosis therapeutics: recent developments at ASBMR (2016) (2)
An overview of osteoporosis (2003) (2)
Corrigendum to “Genetic variation in the beta2-adrenergic receptor but not catecholamine-O-methyltransferase predisposes to chronic pain: Results from the 1958 British Birth Cohort Study” [Pain 149 (2010) 143–151] (2010) (2)
385 ACTIVE APPEARANCE MODELLING OF DXA IMAGES IN THE ASSESSMENT OF KNEE OA (2009) (1)
Seasonal comparison of energy and nutrient intakes from food diaries completed for a longitudinal study (2008) (1)
Multi-disciplinary management of fatigue in ANCA-associated vasculitis: a pilot study (2012) (1)
SHAPE OF THE FEMORAL HEAD AND NECK CORRELATES WITH CLINICAL FEATURES OF OA AND CAN PREDICT PROGRESSION TO TOTAL HIP REPLACEMENT (2009) (1)
The Pharmacoeconomics of Hormone Replacement Therapy (2012) (1)
Predictors for vertebral fracture and fracture threshold in patients using oral corticosteroids. (2002) (1)
Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV). (2012) (1)
Effect of a single 5 mg infusion of zoledronic acid on bone turnover markars vs. oral risedronate (5 mg/day) over 1 year in patients with glucocorticoid-induced osteoporosis (2008) (1)
375 NESTED SHAPE MODELS FOR MEDICAL IMAGE ANALYSIS: CALL FOR CONSENSUS ON HIP SHAPE MODELING (2008) (1)
INFLUENCE OF AGE, GENDER AND VERTEBRAL LEVEL ON THE PREVALENCE OF INDIVIDUAL RADIOGRAPHIC FEATURES OF LUMBAR DISC DEGENERATION (2002) (1)
Aspiration of alendronic acid leading to localized bronchiectasis (2012) (1)
Associations between dietary patterns, tea & coffee drinking and osteoarthritis (2012) (1)
Neural Correlates of Chronic Fatigue in Granulomatosis with Polyangiitis (GPA; Wegener's)-A Functional Magnetic Resonance Imaging (fMRI) Study (2011) (1)
Effect of Zoledronic Acid (Single 5-mg Infusion) on Lumbar Spine Bone Mineral Density Versus Oral Risedronate (5 mg/day) Over 1 Year in Subgroups of Patients Receiving Glucocorticoid Therapy. (2008) (1)
Bone shape, texture and appearance from DXA scans and the relationship with age, body mass index and bone mineral density: an analysis from the opus study (2006) (1)
Influence of nutritional factors on bone mass (2006) (1)
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial (2009) (1)
Relationships between self-reported osteoarthritis (OA), bone mineral density (BMD) and radiographic scores using dual energy X-ray absorptiometry (DXA) (2015) (1)
Erratum: Risk factors for Colles' fracture in men and women: Results from the European Prospective Osteoporosis Study (Osteoporosis International (2003) 14 (213-218) DOI: org/10.1007/s00198-002-1364-1) (2004) (1)
Predicting osteoarthritis progression to total hip replacement : can we do better than risk factors alone using active shape modelling as an imaging biomarker ? (2011) (1)
Risk Factors Associated with Increased Falls in a Hip Fracture Population (1999) (1)
Introducing mobile fracture prevention services with DXA in Northern Scotland: a comparative study of three rural communities (2020) (1)
THRA and DIO 2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women (2014) (1)
Erratum to “Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013” [Maturitas 75 (2013) 392–396] (2013) (1)
A single infusion of zoledronic acid 5 mg is significantly more effective than daily oral risedronate 5 mg in increasing bone mineral density of the lumbar spine, hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (2008) (1)
Bisphosphonates and glucocorticoid osteoporosis in premenopausal women: Results of a randomized controlled trial comparing zoledronic acid with risedronate (2010) (1)
Concise report Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis (2014) (0)
THRA or DIO2 mutations are not a common cause of high bone mass in humans (2013) (0)
Beta-2 adrenergic receptor and catecholamine-O-methyltransferase variants in chronic widespread pain (2008) (0)
Hydroxyapatite Associated Disease in an Elderly Female: Differentiation from Aseptic Necrosis (1989) (0)
Relationships between baseline dheas in postmenopausal women and bone density, bone loss and incident fracture (2010) (0)
P263 FEMORAL SHAPE AND BONE DENSITY FOR ASSESSING HIP OSTEOARTHRITIS (2006) (0)
P025 Does HRT in pre-menopausal women improve bone density and bone turnover markers (1996) (0)
A study of the effect of oestrogen status on bone mineral density in perimenopausal women aged 45–54 (1995) (0)
Population screening for osteoporosis risk in the elderly - Effects on fall and fracture rates (2002) (0)
Latest therapeutic advances in musculoskeletal disease from the ACR 2015 annual conference (2016) (0)
Corticosteroid-Induced Osteoporosis: Can it Be Prevented and Treated? (1998) (0)
Effect of thyroid status on the skeleton in post-menopausal women: the OPUS study (2008) (0)
Ldl-Receptor Related Protein 5 Gene Polymorphisms Influence the Normal Variation of Bone Mineral Density (2004) (0)
426 CORRELATIONS BETWEEN HIP STRUCTURE ANALYSIS AND ACTIVE SHAPE MODELLING IN SUBJECTS WITH OSTEOARTHRITIS (2010) (0)
Charitable funding for osteoporosis (2017) (0)
Which DXA sites to choose for prospective fracture risk assessment? Comparison of different guidelines based on data from the opus study (2009) (0)
Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab? (2020) (0)
Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis – ECCEO 9 – IOF (2009) (0)
Can students learn comparable clinical skills in general practice and hospital settings? Like should be compared with like in a randomised crossover trial. (1998) (0)
Myostatin and myostatin-interacting proteins do not differ between young and sarcopenic men (2010) (0)
Poster 42: Effect of a Single Intravenous Infusion of Zoledronic Acid on Bone Turnover Markers Compared to Oral Risedronate Over 1 Year in Patients with Glucocorticoid‐Induced Osteoporosis (2009) (0)
P335 HYSTERECTOMYAND HRT TREATMENT: AN ASSOCIATION WITH OSTEOARTHRITIS IN EARLY POSTMENOPAUSAL WOMEN? (2006) (0)
Ultrasound and DXA in prediction of second HIP #’s (2006) (0)
Vitamin D supplementation in pregnancy leads to greater bone mass in UK infants born during winter months: the MAVIDOS multicentre, randomised, double-blind, placebo-controlled trial (2016) (0)
Interaction between physical activity and a functional vitamin D receptor gene polymorphism affects bone mineral density (2010) (0)
Dietary flavonoid intakes in early postmenopausal Scottish women (2005) (0)
P38. The cost-effectiveness of appointment systems for screening service for low bone mineral density (1994) (0)
469 GROSS FEMORAL ROTATION MODELLED USING ACTIVE SHAPE MODELS (2010) (0)
Reproducibility and Diagnostic Accuracy of Kellgren-Lawrence Grading for Osteoarthritis using Radiographs and Dual Energy X-ray Absorptiometry ( DXA ) images Running Title : Osteoarthritis grading using DXA (2014) (0)
University of Southern Denmark Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib (2017) (0)
Corrigendum to "Bisphosphonates and glucocorticoid osteoporosis in men: Results of a randomized controlled trial comparing zoledronic acid with risedronate" [Bone 50 (2012) 289-295] (2012) (0)
RELATIONSHIP BETWEEN THE INDIVIDUAL RADIOGRAPHIC FEATURES OF LUMBAR DISC DEGENERATION AND BACK PAIN (2002) (0)
BMD as measured by DXA does not predict incident breast cancer cases in early postmenopausal women (2001) (0)
A mobile DXA scanning service for an island community: addressing geographical inequalities in access to care (2014) (0)
Adjustment of FRAX for women according to BMD at the lumbar spine (2012) (0)
Risedronale is effective in increasing bone density and reducing vertebral fracture risk in patients on glucocorticold therapy (2001) (0)
Quantitative Ultrasound or Dual Energy X-Ray Absorptiometry: The Best Tool for the Assessment of Osteoporosis? (2001) (0)
Active shape and appearance modelling used to identify structural changes in knee osteoarthritis (2012) (0)
Thyroid hormones in the euthyroid range predict subsequent body mass composition in women: the OPUS study (2011) (0)
Between-centre variability of bone density in Europe-An effect of treatmen? The evos study (2006) (0)
National Osteoporosis Society: Abstracts of 11th Conference on Osteoporosis, 25--28 June 2006, Harrogate, UK (2006) (0)
Fracture risk assessment (2011) (0)
Abstract from the Bone and Tooth Society Winter Meeting, December 6, 1993P21. Prediction of traumatic fractures in perimenopausal women using broadband ultrasound attenuation and dual energy x-ray absorptiometry (1994) (0)
INFLUENCE OF LIFESTYLE FACTORS ON RADIOLOGICAL FEATURES OF LUMBAR DISC DEGENERATION (2003) (0)
417 THE EFFECT OF RADIOGRAPHIC POSITIONING ON ACTIVE APPEARANCE MODELLING OF BILATERAL KNEE OSTEOARTHRITIS IN THE OSTEOARTHRITIS INITIATIVE (OAI) (2011) (0)
Current and Future Therapies for Osteoporosis (2002) (0)
Seasonal effects of blood pressure in postmenopausal women (2011) (0)
Relationship between serum lipids and markers of bone health in post-menopausal women (2010) (0)
Pregnancy vitamin D supplementation leads to greater offspring bone mineral density at age 4 years: findings from the MAVIDOS trial (2021) (0)
The Association of Dietary Acidity with Bone Mineral Density in Postmenopausal Women (2006) (0)
Randomised trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib (2016) (0)
Dietary flavonoid intake is associated with bone mineral density in early postmenopausal Scottish women (2007) (0)
Poster 43: Effect of Intravenous Zoledronic Acid on Lumbar Spine Bone Mineral Density Compared to Oral Risedronate in Subgroups of Patients Receiving Glucocorticoid Therapy (2009) (0)
Whole genome association studies of rheumatoid arthritis and replication of identified susceptibility loci (2007) (0)
Bone density and milk. Low recruitment rate may introduce selection bias. (1994) (0)
Is vitamin D status a concern for the overweight and obese? Results from the Aberdeen Nutrition, Sunlight and Vitamin D study (ANSAViD) (2009) (0)
The use of teriparatide in the treatment of postmenopausal osteoporosis: experience of using bone markers and bone mineral density to monitor response (2013) (0)
Recommendationsfortheregistrationofagents forpreventionandtreatmentofglucocorticoid-induced osteoporosis:anupdatefromtheGroupfortheRespect ofEthicsandExcellenceinScience (2008) (0)
Relationship between serum IGF-I and fracture types in postmenopausal women (2012) (0)
Micronutrient interactions and public health, Institute of Child Health, London, UK, 11-12 February 2004 (2004) (0)
Effect of Single Annual Infusion of Zoledronic Acid On Bone Turnover Markers Versus Daily Oral Risedronate in Patients With Glucocorticoid-induced Osteoporosis (2009) (0)
Antiresorptive and anabolic treatment for osteoporosis. (2004) (0)
The non‐hormonal treatment of osteoporosis (1999) (0)
Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function (2012) (0)
GREATER GAINS IN BMD WITH ALENDRONATE THAN RISEDRONATE AFTER 24 MONTHS: RESULTS OF FOSAMAX® ACTONEL® COMPARISON TRIALS (FACTS) - INTERNATIONAL: 86 (2006) (0)
Fall frequency andincidence ofdistal forearm fracture intheUK (1995) (0)
Variations in bone density in Europe and the risk of spinal deformity (1995) (0)
388 CAN LOW RESOLUTION DUAL ENERGY X-RAY ABSORPTIOMETRY IMAGES BE USED TO GRADE OSTEOARTHRITIS SEVERITY? (2011) (0)
Corticosteroids in rheumatoid arthritis. (1986) (0)
The percentage reduction in vertebral fracture risk with lasofoxifene explained by change in spine bone mineral density (2010) (0)
What effect does femoral rotation have on the results of an active shape model (2010) (0)
410 A NEW EXTENDED ACTIVE SHAPE MODEL TO PREDICT TOTAL HIP REPLACEMENT IN PATIENTS WITH OSTEOARTHRITIS (OA) (2008) (0)
A double-blind placebo-controlled trial of the effects of prempak-C on bone density (BMD) and turnover in immediately premenopausal women at risk cf osteoporosis (2006) (0)
11Ala and A Alleles of RUNX2 associated with BMD in Scottish women; interaction of RUNX2 alleles with weight. (2003) (0)
Iron and zinc interactions (2004) (0)
The Role Of C-Type Natriuretic Peptide ( CNP ) In Mouse Fracture Healing (2013) (0)
Eighth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis–ECCEO 8 (2008) (0)
P37. Osteoporosis, HRT and the menopause; attitudes and experience of perimenopausal women attending for bone density screening (1994) (0)
NORTH VS. SOUTH, REGIONAL AND SEASONAL DIFFERENCES IN VITAMIN D STATUS OF UK POSTMENOPAUSAL WOMEN: CAUSE FOR CONCERN? (2009) (0)
Effect of a aingle i.v. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoid-induced osteoporosis (2009) (0)
Lack of Seasonal Variation of Bone Resorption in Elderly Women in Relation to Periodicity of Sunlight Exposure at a Northerly Latitude (57 degrees N) (2008) (0)
Bone densitometry. Can predict those at high risk of fractures. (1994) (0)
Effects of a single 5 mg infusion of zoledronic acid and oral risedronate (5 mg/day) on bone remodeling over one year in patients with glucocorticoid-induced osteoporosis (2008) (0)
P15. Historical self-reported body weight as a predictor of bone mineral density (1992) (0)
Hormones and fracture risk in postmenopausal women: The OPUS study (2009) (0)
THE EPIDEMIOLOGY OF FALLS IN MEN AND WOMEN 50 YEARS AND OVER (1993) (0)
Effect of Single Annual Infusion of Zoledronic Acid (5 Mg) On Lumbar Spine Bone Mineral Density Versus Daily Oral Risedronate (5 Mg) in Subgroups of Patients Receiving Glucocorticoid Therapy (2009) (0)
Endogenous Estradiol and The Risk of Incident Fracture in Postmenopausal Women: The OPUS Study (2012) (0)
Vitamin B-Complex, Methylenetetrahydrofolate Reductase Polymorphism and Bone (2004) (0)
283 VITAMIN D STATUS IS ASSOCIATED WITH LESS BONE MINERAL DENSITY LOSS IN POSTMENOPAUSAL WOMEN WITH SELF-REPORTED OSTEOARTHRITIS (2007) (0)
Bone-density measurement. (1992) (0)
Orthopaedic: soft tissue, metabolism and malignancyOsteomalacia (2006) (0)
Breast vasculitis inassociation withbreast gigantism ina pregnantpatient withsystemic lupus erythematosus (1991) (0)
Effectiveness of zoledronic acid in the prevention and treatment of glucocorticoid-induced osteoporosis in men and premenopausal women (2010) (0)
Non-pharmacological and adjunctive management (2011) (0)
Young Investigator Award) Cod Liver Oil Usage and Holidays Abroad May Help Maintain Vitamin D Status in Scottish Postmenopausal Women Results From a Longitudinal Study (2009) (0)
Dietary flavanones are associated with increased bone mineral density and reduced bone resorption in early postmenopausal Scottish women (2006) (0)
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (0)
Is seasonal variation in vitamin D status affected by holidays and cod liver oil? Results from the Aberdeen Nutrition, Sunlight and Vitamin D study (ANSAViD) (2009) (0)
Risk Assessment and Fracture Discrimination by Ultrasound: The Debate Continues (2005) (0)
ACTN3 R577X genotype and falls in elderly females: Is there a relationship? (2009) (0)
The choice of algorithm for evaluating spine deformities from 6 point placements: use of DXA densitometry (1995) (0)
Comprar Clinical Trials in Rheumatoid Arthritis and Osteoarthritis | Baburaj, Krishnan | 9781852338749 | Springer (2008) (0)
Long-term management (2011) (0)
Investigation of the relationships between osteoarthritis and osteoporosis using dual energy X-ray absorptiometry images (2014) (0)
Bone histomorphometry analyses in glucocorticoid-induced osteoporosis patients treated with once-yearly zoledronic acid or oral risedronate over 1 year (2011) (0)
A calcaneal quantitative ultrasound quality control phantom for cross-calibration and highly precise longitudinal stability tests (2009) (0)
Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David M. Reid?

David M. Reid is affiliated with the following schools:

David M. Reid's Academic­Influence.com Rankings

David M. Reid's Degrees

Similar Degrees You Can Earn

Why Is David M. Reid Influential?

David M. Reid's Published Works

Published Works

What Schools Are Affiliated With David M. Reid?

David M. Reid's AcademicInfluence.com Rankings